Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Janssen, Gliatech extend Alzheimer's disease research agreement

Oct. 27, 1997

SA-4503 offered for licensing by Santen

Oct. 27, 1997

New preclinical data presented on ACEA-1021

Oct. 27, 1997

P&U describes new ergoline derivatives for CNS disorders

Oct. 27, 1997

Histamine H3 ligands prepared by James Black Foundation

Oct. 27, 1997

Researchers at Janssen/Neurocrine Biosciences develop CRF antagonists

Oct. 27, 1997

Development of antipsychotic agent discontinued

Oct. 24, 1997

Serdolect now available in Germany for schizophrenia

Oct. 23, 1997

NeuroSearch evaluates NS-2389 in phase I

Oct. 23, 1997

GDNF reviewed; potential in Parkinson's disease analyzed

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...